Giordano, G., Febbraro, A., Vaccaro, V., Zagonel, V., De Giorgi, U., Melisi, D., Vasile, E., Bianco, R., Lo Re, G., Valente, M., Formica, V., Montesarchio, V., Maiorino, L., Sanna, G., Bittoni, A., Ricci, V., Santini, D., Zaniboni, A., Milella, M., & De Vita, F. (n.d.). 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study. European journal of cancer, 51, S444–. http://access.bl.uk/ark:/81055/vdc_100030628218.0x000007